Patents by Inventor Marion BOSSENEC

Marion BOSSENEC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LYMPHOCYTES EXPRESSING CD73 IN CANCEROUS PATIENT DICTATES THERAPY
    Publication number: 20200232974
    Abstract: The invention discloses a method for selecting a human patient for CD73 antagonist therapy, preferably immunotherapy, comprising the step of determination in a patient's biological sample, that lymphocytes, preferably CD4+ T cells, express CD73, wherein, upon a determination that lymphocytes, preferably CD4+ T cells, express CD73 in patient's biological sample, the patient is declared sensitive to immunotherapy using an antagonist of CD73, preferably an anti-CD73 antibody. Combined therapy with immunotherapy against an inhibitory ICP and/or with a chemotherapeutic agent sensitive to MDR1 exclusion activity is proposed.
    Type: Application
    Filed: March 30, 2017
    Publication date: July 23, 2020
    Inventors: Christine MENETRIER-CAUX, Nicolas GOURDIN, Christophe CAUX, Selena VIGANO, Pedro ROMERO, Marion BOSSENEC